𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

✍ Scribed by Holm Eggemann, Atanas Ignatov, Bobbie J. Smith, Udo Altmann, Gunter von Minckwitz, Freidrich W. Röhl, Mark Jahn, Serban-Dan Costa


Book ID
118796838
Publisher
Springer US
Year
2012
Tongue
English
Weight
206 KB
Volume
137
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Identifying breast cancer patients most
✍ Christopher M. Booth; Joseph L. Pater; Paul E. Goss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Identifying Breast Cancer Patients Most Likely to Benefit From Aromatase Inhibitor Therapy After Adjuvant Tamoxifen W e are responding to the recently published study by Freedman and colleagues in which it is suggested that the benefits of adding an aromatase inhibitor after 5 years of adjuvant tamo